“Real-World Switch Rates of Risankizumab and Other Biologics in Psoriasis Patients With Psoriatic Arthritis” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s443. doi:10.25251/skin.8.supp.443.